[Metastasized renal cell carcinoma - research subjects needed!].
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy* / Q000473:pathology; D004334:Drug Administration Schedule; D006801:Humans; D007191:Indazoles; D007680:Kidney Neoplasms / Q000188:drug therapy* / Q000473:pathology; D015337:Multicenter Studies as Topic; D009362:Neoplasm Metastasis; D009536:Niacinamide / Q000008:administration & dosage / Q000031:analogs & derivatives*; D018579:Patient Selection; D010671:Phenylurea Compounds / Q000008:administration & dosage*; D011743:Pyrimidines / Q000009:adverse effects*; D016032:Randomized Controlled Trials as Topic; D000077157:Sorafenib; D013449:Sulfonamides / Q000009:adverse effects*
D007191:Indazoles; D010671:Phenylurea Compounds; D011743:Pyrimidines; D013449:Sulfonamides; D009536:Niacinamide; C516667:pazopanib; D000077157:Sorafenib